Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Women with AGA have higher lipid levels, increasing heart disease risk.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Healthcare providers need better education and policies to serve transgender individuals effectively.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

A thorough skin history and examination are essential for diagnosing and treating skin conditions effectively.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

DHT, a testosterone byproduct, causes male pattern baldness.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Melatonin affects skin cell growth differently based on how much and how long it's used.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Some skin diseases and their treatments can negatively affect male fertility.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Women of color in Northern Manhattan view hair care as important to their identity and culture, and education on harmful chemicals in hair products is needed.

PSA might help diagnose PCOS and related skin issues, but more research is needed.